NEW YORK ( TheStreet) -- CHANGE IN RATINGSAthenaHealth ( ATHN) downgraded at Oppenheimer from Perform to Underperform. Company risks a slowdown in its core business. Brown-Forman ( BF.B) upgraded at UBS from Sell to Neutral. $58 price target. Fundamentals are likely to improve and the stock no longer trades at a sizable premium. Burger King ( BKC) upgraded at Deutsche from Hold to Buy. $24 price target. Stock has underperformed the market and fundamentals may be near an inflection point. Broadcom ( BRCM) upgraded at Goldman from Neutral to Buy. Estimates also raised, as the company is gaining market share and can benefit from secular growth trends. $40 price target. Avis Budget ( CAR) upgraded at Barclays to Overweight from Equal Weight on strong 2011 earnings potential. Price target jumped to $15 from $12. 2010 EPS estimate lowered to 62 cents, 2011 introduced at a dollar. Eurand ( EURX) downgraded at BofA/Merrill to Underperform from Neutral as upside is limited. Maintain $11 price target. Glacier Bancorp ( GBCI) upgraded at Suntrust from Neutral to Buy. Shares are attractive, based on normalized earnings. $20 price target. Impax Labs ( IPXL) downgraded at BofA/Merrill to Underperform from Neutral as positive outlook is already priced into shares. Maintain $17 price target. Joy Global ( JOYG) rated new Equal-weight at Morgan Stanley. $60 price target. LSI ( LSI) downgraded at Goldman from Buy to Neutral. Market is now pricing in a cyclical recovery in IT spending. $6.50 price target. LSI ( LSI) upgraded at Kaufman from Hold to Buy. $8 price target. Company is seeing positive momentum in design wins. Nike ( NKE) upgraded at FBR from Market Perform to Outperform. $84 price target. Company sees visibility for top-line growth. Polycom ( PLCM) downgraded at BofA/Merrill to Neutral from Buy on unattractive valuation. Price target raised to $35 from $32.
Cisco ( CSCO) target boosted at Stifel. Shares of CSCO now seen reaching $29. Product upgrades should drive sales. Buy rating. Foster Wheeler ( FWLT) estimate changed at Barclays. FWLT 2011 EPS estimates introduced at $2.50, 2010 maintained at $2.30. Reiterate Overweight rating and $38 price target. Guess ( GES) price target raised at Credit Suisse. GES price target increased to $60 from $55 on excellent 4Q09 results. 2011 EPS estimate lifted to $3.00, 2012 held at $3.50. Maintain Outperform rating. Green Mountain ( GMCR) target increased at Piper. Shares of GMCR now seen reaching $105. Store checks suggest strong sales trends. Overweight rating. Global Payments ( GPN) estimates increased at Goldman. GPN estimates were boosted through 2012. Company is seeing a slow turnaround in the consumer. Neutral rating and $50 price target. IHS ( IHS) estimates lowered at Goldman through 2012. Company is facing a higher pension expense. Neutral rating and $58 price target. JC Penney ( JCP)target, estimates boosted at Citi. Price target increased to $45 from $43. JCP is well-positioned to deliver strong 2H10 results, Citigroup said. 2011 and 2012 EPS estimates improved to $1.65 and $2.11, respectively. Maintain Buy rating. Nike ( NKE) target, estimates raised at Citi. NKE price target increased to $80 from $75. 2010 and 2011 EPS estimates lifted to $3.86 and $4.40, Respectively. Maintain Buy rating. Nike ( NKE) target, estimates boosted at Barclays. NKE price target increased to $85 from $75 on strong 3Q10 results. 2010 and 2011 EPS estimates improved to $3.85 and $4.35, respectively. Maintain Overweight rating. Nike ( NKE) estimates, target raised at Goldman. NKE estimates were increased through 2012. Gross margin is moving higher and the company is seeing better futures growth. Buy rating and new $80 price target. Research in Motion ( RIMM) estimates upped at Oppenheimer. RIMM 2010 estimates were raised because of positive channel checks. Demand strongest in lower-priced items. Outperform rating. United Technologies ( UTX) target, estimate boosted at Barclays. UTX price target jumped to $81 from $76 after an upbeat analyst day. 2010 EPS estimate increased 5 cents to $4.60. Maintain Overweight rating. WellPoint ( WLP) estimate increased at Barclays. WLP 2010 EPS estimate raised 10 cents to $6.10, 2011 introduced at $6.50. Strong 2010 outlook. Maintain Overweight rating and $74 price target.